Literature DB >> 22909116

Characterization of released polypeptides during an interferon-γ-dependent antibacterial response in airway epithelial cells.

Mette Eliasson1, Anders I Olin, Johan A Malmström, Matthias Mörgelin, Mikael Bodelsson, Mattias Collin, Arne Egesten.   

Abstract

When pathogenic bacteria breach the epithelial lining at mucosal surfaces, rapidly available innate immune mechanisms are critical to halt the infection. In the present study, we characterized the production of antibacterial polypeptides released by epithelial cells. IFN-γ, but neither TNF nor IL-1β alone, induced release of antibacterial activity to a cell culture medium, causing a lytic appearance of killed bacteria as revealed by electron microscopy. Addition of the protein streptococcal inhibitor of complement, derived from Streptococcus pyogenes, known for its ability to neutralize antimicrobial polypeptides (AMPs), reduced the antibacterial activity of the medium. Characterization of the antibacterial incubation medium using mass spectrometric approaches and ELISAs, displayed presence of several classical AMPs, antibacterial chemokines, as well as complement factors and proteases that may interfere with bacterial killing. Many were constitutively produced, that is, being released by cells incubated in a medium alone. While a combination of IFN-γ and TNF did not increase bacterial killing, the presence of TNF boosted the amounts and detectable number of AMPs, including antibacterial chemokines. However, the methods applied in the study failed to single out certain AMPs as critical mediators, but rather demonstrate the broad range of molecules involved. Since many AMPs are highly amphiphatic in nature (i.e., cationic and hydrophobic), it is possible that difficulties in optimizing recovery present limitations in the context investigated. The findings demonstrate that epithelial cells have a constitutive production of AMPs and that IFN-γ is an important inducer of an antibacterial response in which is likely to be a critical part of the innate host defense against pathogenic bacteria at mucosal surfaces.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22909116      PMCID: PMC3493045          DOI: 10.1089/jir.2012.0017

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  63 in total

1.  Cutting edge: IFN-inducible ELR- CXC chemokines display defensin-like antimicrobial activity.

Authors:  A M Cole; T Ganz; A M Liese; M D Burdick; L Liu; R M Strieter
Journal:  J Immunol       Date:  2001-07-15       Impact factor: 5.422

2.  Dermcidin: a novel human antibiotic peptide secreted by sweat glands.

Authors:  B Schittek; R Hipfel; B Sauer; J Bauer; H Kalbacher; S Stevanovic; M Schirle; K Schroeder; N Blin; F Meier; G Rassner; C Garbe
Journal:  Nat Immunol       Date:  2001-12       Impact factor: 25.606

Review 3.  The role of cationic antimicrobial peptides in innate host defences.

Authors:  R E Hancock; G Diamond
Journal:  Trends Microbiol       Date:  2000-09       Impact factor: 17.079

4.  Regulation of SLPI and elafin release from bronchial epithelial cells by neutrophil defensins.

Authors:  S van Wetering; A C van der Linden; M A van Sterkenburg; W I de Boer; A L Kuijpers; J Schalkwijk; P S Hiemstra
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-01       Impact factor: 5.464

5.  Dermatan sulphate is released by proteinases of common pathogenic bacteria and inactivates antibacterial alpha-defensin.

Authors:  A Schmidtchen; I M Frick; L Björck
Journal:  Mol Microbiol       Date:  2001-02       Impact factor: 3.501

6.  The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells.

Authors:  A Sauty; M Dziejman; R A Taha; A S Iarossi; K Neote; E A Garcia-Zepeda; Q Hamid; A D Luster
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

7.  Synergistic and additive killing by antimicrobial factors found in human airway surface liquid.

Authors:  P K Singh; B F Tack; P B McCray; M J Welsh
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-11       Impact factor: 5.464

Review 8.  Chemokines in pathology and medicine.

Authors:  M Baggiolini
Journal:  J Intern Med       Date:  2001-08       Impact factor: 8.989

Review 9.  Pathogenesis of group A streptococcal infections.

Authors:  M W Cunningham
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

10.  LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells.

Authors:  Q Chen; A P Schmidt; G M Anderson; J M Wang; J Wooters; J J Oppenheim; O Chertov
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

View more
  1 in total

1.  The Opp (AmiACDEF) Oligopeptide Transporter Mediates Resistance of Serotype 2 Streptococcus pneumoniae D39 to Killing by Chemokine CXCL10 and Other Antimicrobial Peptides.

Authors:  Kevin E Bruce; Britta E Rued; Ho-Ching Tiffany Tsui; Malcolm E Winkler
Journal:  J Bacteriol       Date:  2018-05-09       Impact factor: 3.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.